4De Geare VS,Boura JA,Grines LL,et al.Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction[J].Am J Cardiol,2001,87(9):1035-1038.
2Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿（译）,David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志（中文版）,2007,26(3):131-139. 被引量：59
4Aschenbrenner DS. Factors that decrease the effectiveness of clopidogrel[J]. Am J Nurs, 2009, 109(6):66-67.
5Sibbing D, Morath T, Stegherr J, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel[J]. Thromb Haeost, 2009, 101(4):714-719.
6Deny S, Loke YK. Risk of gastrointestinal haeorrhage with long term use of aspirin: meta-analysis[J]. BMJ, 2000, 321 (7270): 1183-1187.
7Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and cloidogrel[J]. CMAJ, 2009, 180(7):713-718.
8Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of cloidogrel and proton pump inhibitors following acute coronary syndrome[J]. JAMA, 2009, 301 (9):937-944.
9Geisler T, Schaeffeler E, Dippon J, et al. CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation[J]. Pharmacogenomics, 2008, 9(9): 1251-1259.
10Neubauer H, Engelhardt A, Kruger JC, et al. Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting[J]. J Cardiovase Pharmaco, 2010, 56(1):91-97.
